Monday 23rd May 2016 |
Text too small? |
Abano Healthcare Group has agreed to sell its 50 percent stake in audiology company Bay International to interests associated with Peter Hutson for $32 million. The listed medical and dental centre investor also said earnings would be at the top end of guidance
The transaction follows an unsolicited approach from an international hearing device manufacturer, which triggered Hutson's pre-emptive rights under Bay's shareholder agreement, which allowed him to acquire the shares at the same price, the Auckland-based company said in a statement.
Last month, Abano said it received an approach from a third party that it didn't name offering almost three times book value for its share of Bay, which owns Bay Audio, an audiology retail network in Australia with a smaller footprint in South East Asia.
Abano chief executive Richard Keys said the sale would generate a surplus over book value of approximately $20 million once Abano's A$1.8 million share of Bay Audio Australia’s deferred tax asset was recognised. The sale was in keeping with Abano's focus on its growing trans-Tasman dental business.
Abano said excluding the impact of the Bay sale, its results for the 2016 financial year would be at the top end of the $8.2 million to $9 million underlying profit guidance it gave on April 7. Profit in 2015 was $8.8 million, or $5.6 million excluding two businesses it has since sold.
Proceeds from the Bay sale will be used to repay debt and help fund Abano's continued expansion of its Lumino The Dentists network in New Zealand and Maven Dental Group in Australia, Keys said.
Settlement of the sale is expected in the next three months.
Abano shares last traded at $7.65 and have edged up 1.6 percent in the past 12 months.
BusinessDesk.co.nz
No comments yet
PaySauce Quarterly Market Update - Dec 2024
CHI - FY24 Results Date and Audio Conference Details
AIA - December 2024 Monthly traffic update
January 15th Morning Report
PF - Details of Interim Results Webcast
Scott Secures NZ$18 million in Global Contracts for Protein
January 14th Morning Report
AFT - NEW YEAR LETTER TO INVESTORS
TruScreen Invited to Present WHO AI Collaboration Meeting
January 13th Morning Report